These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11448511)

  • 21. Endogenous cannabinoids trigger the depolarization-induced suppression of excitation in the lateral amygdala.
    Kodirov SA; Jasiewicz J; Amirmahani P; Psyrakis D; Bonni K; Wehrmeister M; Lutz B
    Learn Mem; 2010 Jan; 17(1):43-9. PubMed ID: 20042481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord.
    Salio C; Fischer J; Franzoni MF; Conrath M
    Neuroscience; 2002; 110(4):755-64. PubMed ID: 11934482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons.
    Irving AJ; Coutts AA; Harvey J; Rae MG; Mackie K; Bewick GS; Pertwee RG
    Neuroscience; 2000; 98(2):253-62. PubMed ID: 10854756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.
    Szabo B; Wallmichrath I; Mathonia P; Pfreundtner C
    Neuroscience; 2000; 97(1):89-97. PubMed ID: 10771342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptic specificity of endocannabinoid signaling in the hippocampus.
    Wilson RI; Kunos G; Nicoll RA
    Neuron; 2001 Aug; 31(3):453-62. PubMed ID: 11516401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.
    Uchigashima M; Narushima M; Fukaya M; Katona I; Kano M; Watanabe M
    J Neurosci; 2007 Apr; 27(14):3663-76. PubMed ID: 17409230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiology of Endocannabinoid Signaling.
    Musella A; Centonze D
    Methods Mol Biol; 2023; 2576():461-475. PubMed ID: 36152210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites.
    Tamaru Y; Nomura S; Mizuno N; Shigemoto R
    Neuroscience; 2001; 106(3):481-503. PubMed ID: 11591452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures.
    Ohno-Shosaku T; Sawada S; Kano M
    Neurosci Res; 2000 Jan; 36(1):67-71. PubMed ID: 10678533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excitement reduces inhibition via endocannabinoids.
    Freund TF; Hájos N
    Neuron; 2003 May; 38(3):362-5. PubMed ID: 12741983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.
    Yanovsky Y; Mades S; Misgeld U
    Neuroscience; 2003; 122(2):317-28. PubMed ID: 14614899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnenolone does not interfere with the effects of cannabinoids on synaptic transmission in the cerebellum and the nucleus accumbens.
    Krohmer A; Brehm M; Auwärter V; Szabo B
    Pharmacol Res; 2017 Sep; 123():51-61. PubMed ID: 28655644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons.
    Sullivan JM
    J Neurophysiol; 1999 Sep; 82(3):1286-94. PubMed ID: 10482747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered presynaptic vesicle release and cycling during mGluR-dependent LTD.
    Zakharenko SS; Zablow L; Siegelbaum SA
    Neuron; 2002 Sep; 35(6):1099-110. PubMed ID: 12354399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons.
    Nyíri G; Cserép C; Szabadits E; Mackie K; Freund TF
    Neuroscience; 2005; 136(3):811-22. PubMed ID: 16344153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse.
    Sun JY; Wu LG
    Neuron; 2001 Apr; 30(1):171-82. PubMed ID: 11343653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids.
    Lozovaya N; Yatsenko N; Beketov A; Tsintsadze T; Burnashev N
    J Neurosci; 2005 Aug; 25(33):7499-506. PubMed ID: 16107637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions of cannabinoid receptors in the hippocampus.
    Davies SN; Pertwee RG; Riedel G
    Neuropharmacology; 2002 Jun; 42(8):993-1007. PubMed ID: 12128000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid physiology and pharmacology: 30 years of progress.
    Howlett AC; Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Porrino LJ
    Neuropharmacology; 2004; 47 Suppl 1():345-58. PubMed ID: 15464149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.